Bayer books bumper Q3 as Monsanto merger waits in wings

German chemicals and pharmaceuticals giant Bayer said Thursday it booked a huge windfall gain in the third quarter, but the group is still waiting for approval of its mega-merger with US seeds and pesticides maker Monsanto.

Reading the genetic signature of the sea scallop

Scallops are one of the most profitable fisheries in Maine, with a statewide value of nearly $7 million in 2016. The scallop fishery is also one of the most local, with small "day boats" staying close to shore.

Bayer stock plunges on profit warning

Shares in German chemicals and pharmaceuticals giant Bayer plummeted in Frankfurt Friday, after it issued a profit warning over weak performance at its agrochemical and over-the-counter medicines units.

Bayer says Monsanto deal on track, eyes record 2017

German pharmaceuticals and chemicals giant Bayer on Wednesday said it expected further growth this year after a record performance in 2016, as its mammoth takeover of US seedmaker Monsanto remains on track.

Five things to know about the Bayer-Monsanto deal

German chemicals firm Bayer on Wednesday clinched a $66-billion deal to buy the US seeds and pesticides giant Monsanto, a high-profile takeover likely to face close scrutiny as debate rages in Europe over the use of genetically ...

Bayer takeover of Monsanto would create global giant

Bayer's potential acquisition of Monsanto would create a giant seed and farm chemical company with a strong footprint in the U.S., Europe and Asia, combining two businesses with complementary geographical focus.

Bayer says bottom line down in Q1

German chemicals and pharmaceuticals giant Bayer, maker of Aspirin, said Thursday that net profits were down in the first three months, but it nevertheless raised its full-year forecasts due to the positive effects of the ...

page 5 from 6